Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | PERCEPTIVE ADVISORS LLC | 4,731,150 5.100% | -3,230,997 (-40.58%) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | Anteris Technologies Global Corp. AVR | PERCEPTIVE ADVISORS LLC | 2,440,000 6.700% | 2,440,000 (New Position) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | Adagio Medical Holdings, Inc. ADGM | PERCEPTIVE ADVISORS LLC | 15,321,655 73.600% | 64,167 (+0.42%) | Filing History |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | PERCEPTIVE ADVISORS LLC | 22,112,266 7.300% | -4,505,443 (-16.93%) | Filing History |
| 2025-01-31 9:06 pm Unchanged | 2025-01-31 | 13D | Nautilus Biotechnology, Inc. NAUT | PERCEPTIVE ADVISORS LLC | 12,594,211 10.000% | 0 (Unchanged) | Filing History |
| 2025-01-08 9:28 pm Purchase | 2024-12-31 | 13G | Traws Pharma, Inc. TRAW | PERCEPTIVE ADVISORS LLC | 386,555 9.900% | 386,555 (New Position) | Filing History |
| 2024-12-16 9:02 pm Unchanged | 2024-12-12 | 13D | Lyra Therapeutics, Inc. LYRA | PERCEPTIVE ADVISORS LLC | 12,757,562 19.500% | 0 (Unchanged) | Filing History |
| 2024-12-09 6:22 pm Purchase | 2024-12-05 | 13G | Verrica Pharmaceuticals Inc. VRCA | PERCEPTIVE ADVISORS LLC | 7,962,147 8.700% | 862,965 (+12.16%) | Filing History |
| 2024-11-19 9:44 pm Sale | 2024-11-14 | 13D | Soleno Therapeutics, Inc. SLNO | PERCEPTIVE ADVISORS LLC | 1,770,792 4.100% | -1,684,184 (-48.75%) | Filing History |
| 2024-11-14 9:50 pm Purchase | 2024-09-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | PERCEPTIVE ADVISORS LLC | 5,435,210 8.600% | 291,635 (+5.67%) | Filing History |
| 2024-11-14 8:14 pm Purchase | 2024-05-30 | 13G | Inhibrx Biosciences, Inc. INBX | PERCEPTIVE ADVISORS LLC | 1,488,553 9.900% | 1,488,553 (New Position) | Filing History |
| 2024-11-14 7:59 pm Purchase | 2024-11-14 | 13D | Solid Biosciences Inc. SLDB | PERCEPTIVE ADVISORS LLC | 6,934,678 17.300% | 6,934,678 (New Position) | Filing History |
| 2024-11-14 5:26 pm Unchanged | 2024-08-28 | 13D | Trinity Biotech plc TRIB | PERCEPTIVE ADVISORS LLC | 56,000,000 22.600% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:50 pm Purchase | 2024-09-30 | 13G | enVVeno Medical Corporation NVNO | PERCEPTIVE ADVISORS LLC | 1,869,219 9.900% | 474,503 (+34.02%) | Filing History |
| 2024-11-14 4:50 pm Purchase | 2024-09-30 | 13G | Iovance Biotherapeutics, Inc. IOVA | PERCEPTIVE ADVISORS LLC | 26,617,709 8.800% | 7,395,966 (+38.48%) | Filing History |
| 2024-11-14 4:50 pm Sale | 2024-09-30 | 13G | Viridian Therapeutics, Inc. VRDN | PERCEPTIVE ADVISORS LLC | 2,812,665 3.800% | -1,209,401 (-30.07%) | Filing History |
| 2024-11-14 4:50 pm Purchase | 2024-09-30 | 13G | Aldeyra Therapeutics, Inc. ALDX | PERCEPTIVE ADVISORS LLC | 9,275,851 15.600% | 682,265 (+7.94%) | Filing History |
| 2024-11-14 4:50 pm Purchase | 2024-09-30 | 13G | Precision BioSciences, Inc. DTIL | PERCEPTIVE ADVISORS LLC | 426,293 5.900% | 426,293 (New Position) | Filing History |
| 2024-11-14 4:50 pm Purchase | 2024-09-30 | 13G | Verona Pharma plc VRNA | PERCEPTIVE ADVISORS LLC | 6,565,933 8.100% | 1,447,788 (+28.29%) | Filing History |
| 2024-11-14 4:50 pm Purchase | 2024-09-30 | 13G | Nuvalent, Inc. NUVL | PERCEPTIVE ADVISORS LLC | 2,979,235 4.600% | 61,244 (+2.10%) | Filing History |